Press Releases

Showing 1-35 of 253


2013

May

May 21

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 9

Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes

May 8

Abbott to Present at UBS Global Healthcare Conference

May 7

New Parenting Survey Reveals That Nearly All Moms Feel Judged on Parenting Decisions
 

April

April 18

Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients

April 17

Abbott Reports First-Quarter 2013 Results

April 16

Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand

April 15

Abbott Initiates Voluntary Recall of FreeStyle InsuLinx® Blood Glucose Meters in the United States

April 10

Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient

April 1

Abbott Hosts Conference Call for First-Quarter Earnings
 

March

March 28

New Abbott Test Can Help Doctors Detect the Presence of Two Important Health Issues

March 20

FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery

March 11

New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold

March 10

Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery

March 7

Abbott to Present at Barclays Capital 2013 Global Healthcare Conference

March 4

Abbott Introduces Nutrition for Active Kids - Kidz ZonePerfect® Nutrition Bars
 

February

February 21

Abbott to Collaborate with Janssen and Pharmacyclics on Development of Companion Test for Investigational Leukemia Therapy

February 15

Abbott Declares 357th Consecutive Quarterly Dividend

February 12

New Survey Reveals Eight in 10 Fitness Enthusiasts Are Not Doing Enough to Aid Recovery After Exercise
 

January

January 23

Abbott Reports Fourth-Quarter and Full-Year 2012 Results

January 21

Abbott and AbbVie Named to S&P Dividend Aristocrats Indices

January 14

Abbott and AbbVie Announce Investor Calls

January 9

New Abbott Test Available in Europe Provides Novel Tool to Aid Doctors in Evaluating Potential Heart Attacks

January 8

Abbott Initiates Clinical Trial of Absorb™ in the United States

January 3

Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent System

January 2

Abbott Completes Separation of Research-Based Pharmaceuticals Business

2012

December

December 21

Abbott and AbbVie to Present at Financial Conferences

December 17

Abbott Announces New Testosterone Test to Measure the Hormone at Low Levels

December 17

AbbVie Inc. Common Stock Approved for Listing on NYSE Euronext Paris

December 14

Abbott Declares 356th Consecutive Quarterly Dividend

December 13

New Study Shows Promising Results For Tests That Can Help Doctors Better Evaluate Potential Heart Attacks

December 7

Abbott Announces Effectiveness of AbbVie Form 10 Registration Statement
 

November

November 28

Abbott Board of Directors Approves Separation of AbbVie and Declares Special Dividend Distribution of AbbVie Stock

November 27

Abbott’s HUMIRA® (Adalimumab) Approved in Europe for Severe Active Pediatric Crohn’s Disease

November 13

Abbott Announces Phase 3 Hepatitis C Program Details